Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2004 December;52(6) > Minerva Cardioangiologica 2004 December;52(6):521-4

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  HEART FAILURE 

Minerva Cardioangiologica 2004 December;52(6):521-4

Copyright © 2004 EDIZIONI MINERVA MEDICA

language: English

Heart failure therapy and sudden cardiac death prevention

Morgan J. M.


PDF


Primary prophylaxis of sudden cardiac death by implantable defibrillators is an accepted therapeutic strategy because sudden cardiac death is reduced by their use. However, many patients at risk of sudden cardiac death due to left ventricular systolic dysfunction also suffer heart failure symptoms. There is increasing evidence that the morbidity of heart failure can be alleviated by device therapy in which ventricular dysynchrony is improved by biventricular pacing. Both therapies in the same device can reduce both morbidity and mortality. Device therapy is an important new aspect in the field of heart failure management.

top of page